Epstein-Barr Virus and CNS Infections

Neuroviral Infections: General Principles and DNA Viruses

Volumn , Issue , 2013, Pages 245-272

  Volpi, Antonio ^a   Pica, Francesca ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899984800     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13907-11     Document Type: Chapter

References (128)

1. Ablashi, D.V., Eastman, H.B., Owen, C.B. et al. (2000). Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 16, 179-191.
2. Ambinder, R.F. (2001). Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 37, 1209-1216.
3. Ambler, M., Stoll, J., Tzamaloukas, A., and Albala, M.M. (1971). Focal encephalomyelitis in infectious mononucleosis. A report with pathological description. Ann Intern Med 75, 579-583.
4. Anagnostopoulos, I., Hummel, M., Kreschel, C., and Stein, H. (1995). Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85, 744-750.
5. Annels, N.E., Kalpoe, J.S., Bredius, G. et al. (2006). Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution. Clin Infect Dis 42, 1743-1748.
6. Arribas, J.R., Clifford, D.B., Fichtenbaum, C.J., Roberts, R.L., Powderly, W., and Storch, G.A. (1995). Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS related central nervous system lymphoma. J Clin Microbiol 33, 1580-1583.
7. Ascherio, A. and Munch, M. (2000). Epstein-Barr virus and multiple sclerosis. Epidemiology 11, 220-224.
8. Ascherio, A., Munger, K., Lennette, E. et al. (2001). Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286, 3083-3088.
9. Babcock, G.J., Decker, L.L., Volk, M., and Thorley-Lawson, D.A. (1998). EBV persistence in memory B cells in vivo. Immunity 9, 395-404.
10. Baumgarten, E., Herbst, H., Schmitt, M., Seeger, K.H., Schulte-Overberg, U., and Henze, G. (1994). Life-threatening infectious mononucleosis: is it correlated with virus-induced T cell proliferation? Clin Infect Dis 19, 152-156.
11. Bell, A.I., Groves, K., Kelly, G.L. et al. (2006). Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt’s lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87, 2885-2890.
12. Bennett, J.L., Lam, C., Kalluri, S.R. et al. (2009). Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66, 617-629.
13. Bertram, G., Dreiner, N., Krueger, G.R. et al. (1991). Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis. In Vivo 5, 271-279.
14. Bhatti, N., Larson, E., Hickey, M., and Seal, D. (1990). Encephalitis due to Epstein-Barr virus. J Infect 20, 69-72.
15. Bonney, D.K., Htwe, E.E., Turner, A. et al. (2011). Sustained response to intrathecal rituximab in EBV associated post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant. Pediatr Blood Cancer. doi: 10.1002/pbc.23134 [Epub ahead of print].
16. Borza, C.M. and Hutt-Fletcher, L.M. (2002). Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8, 594-599.
17. Boughton, C.R. (1970). Neurological complications of glandular fever. Med J Aust 2, 573-575.
18. Brink, N.S., Sharvell, Y., Howard, M.R., Fox, J.D., Harrison, M.J., and Miller, R.F. (1998). Detection of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease. J Neurol Neurosurg Psychiatry 65, 191-195.
19. Broccolo, F., Iuliano, R., Careddu, A.M. et al. (2000). Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease. Acta Virol 44, 137-143.
20. Brooks, L., Yao, Q.Y., Rickinson, A.B., and Young, L.S. (1992). Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66, 2689-2697.
21. Burgoon, M., Hammack, B., Owens, G., Maybach, A., Eikelenboom, M., and Gilden, D. (2003). Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Ann Neurol 54, 459-463.
22. Burgoon, M., Keays, K., Owens, G. et al. (2005). Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc Natl Acad Sci USA 102, 7245-7250.
23. Cepok, S., Zhou, D., Srivastava, R. et al. (2005). Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115, 1352-1360.
24. Cingolani, A., Gastaldi, R., Fassone, L. et al. (2000). Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin’s lymphomas. J Clin Oncol 18, 3325-3330.
25. Cinque, P., Brytting, M., Vago, L. et al. (1993). Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342, 398-401.
26. Clave, E., Agbalika, F., Bajzik, V. et al. (2004). Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy. Transplantation 77, 76-84.
27. Cohen, J.I. (2000). Epstein-Barr virus infection. N Engl J Med 343, 481-492.
28. Cote, T.R., Manns, A., Hardy, C.R., Yellin, F.J., and Hartge, P. (1996). Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88, 675-679.
29. Cotton, M.F., Reiley, T., Robinson, C.C., Pedneault, L., Alfieri, C., and Simoes, E.A. (1994). Acute aqueductal stenosis in a patient with Epstein-Barr virus infectious mononucleosis. Pediatr Infect Dis J 13, 224-227.
30. Cotton, P.B. and Webb-Peploe, M.M. (1966). Acute transverse myelitis as a complication of glandular fever. Br Med J 5488, 654-655.
31. Darenkov, I.A., Marcarelli, M.A., Basadonna, G.P. et al. (1997). Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 64, 848-852.
32. Davis, C.L., Harrison, K.L., McVicar, J.P., Forg, P.J., Bronner, M.P., and Marsh, C.L. (1995). Antiviral prophylaxis and the Epstein Barr virus-related posttransplant lymphoproliferative disorder. Clin Transplant 9, 53-59.
33. D’Amico, A., Messa, C., Castagna, A. et al. (1997). Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 18, 741-750.
34. Deacon, E.M., Pallesen, G., Niedobitek, G. et al. (1993). Epstein-Barr virus and Hodgkin’s disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 177, 339-349.
35. Dellemijn, P.L., Brandenburg, A., Niesters, H.G., van den Bent, M.J., Rothbarth, P.H., and Vlasveld, L.T. (1995). Successful treatment with ganciclovir of presumed Epstein-Barr meningoencephalitis following bone marrow transplant. Bone Marrow Transplant 16, 311-312.
36. Domachowske, J.B., Cunningham, C.K., Cummings, D.L., Crosley, C.J., Hannan, W.P., and Weiner, L.B. (1996). Acute manifestations and neurologic sequelae of Epstein-Barr virus encephalitis in children. Pediatr Infect Dis J 15, 871-875.
37. Dowling, P.C. and Cook, S.D. (1981). Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases. Ann Neurol 9, 44-55.
38. Epstein, M.A., Achong, B.G., and Barr, Y.M. (1964). Virus particles in cultured lymphoblast from Burkitt’s lymphoma. Lancet 1, 702-703.
39. Epstein, M.A., Henle, G., Achong, B.G., and Barr, Y.M. (1965). Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma. J Exp Med 121, 761-770.
40. Epstein, M.A. and Achong, B.G. (1979). The Epstein-Barr Virus. Berlin Heidelberg, New York: Springer-Verlag.
41. Fine, H.A. and Mayer, R.J. (1993). Primary central nervous system lymphoma. Ann Intern Med 119, 1093-1104.
42. Fingeroth, J.D., Weis, J.J., Tedder, T.F., Strominger, J.L., Biro, P.A., and Fearon, D.T. (1984). Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81, 4510-4514.
43. Fischer, E., Delibrias, C., and Kazatchkine, M.D. (1991). Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146, 865-869.
44. Forghani, B., Cremer, N., Johnson, K., Fein, G., and Likosky, W. (1980). Comprehensive viral immunology of multiple sclerosis: III: analysis of CSF antibodies by radioimmunoassay. Arch Neurol 37, 616-619.
45. Gautier-Smith, P.C. (1967). Clinical aspects of spinal neurofibromas. Brain 90, 359-394.
46. Gerber, P. and Rosenblum, E.N. (1968). The incidence of complement-fixing antibodies to herpes simplex and herpes-like viruses in man and rhesus monkeys. Proc Soc Exp Biol Med 128, 541-546.
47. Gilden, D. (2005). Infectious causes of multiple sclerosis. Lancet Neurol 4, 195-202.
48. Goldman, M., Reisher, J.I., and Bushar, H.F. (1968). Serum-antibodies to Burkitt cell virus. Lancet 1, 1156.
49. Green, M., Kaufmann, M., Wilson, J., and Reyes, J. (1997). Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. Clin Infect Dis 25, 1344-1349.
50. Gulley, M.L. (2001). Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 3, 1-10.
51. Hahn, A.F. (1998). Guillain-Barré syndrome. Lancet 352, 635-641.
52. Hanel, M., Fiedler, F., and Thorns, C. (2001). Anti-CD20 monoclonal antibody (Rituximab) and cidofovir as successful treatment of an EBV associated lymphoma with CNS involvement. Onkologie 24, 491-494.
53. Henle, G. and Henle, W. (1966a). Studies on cell lines derived from Burkitt’s lymphoma. Trans NY Acad Sci 29, 71-79.
54. Henle, G. and Henle, W. (1966b). Immunofluorescence in cells derived from Burkitt’s lymphoma. J Bacteriol 91, 1248-1256.
55. Hislop, A.D., Taylor, G.S., Sauce, D., and Rickinson, A.B. (2007). Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25, 587-617.
56. Hochberg, D., Middeldorp, J.M., Catalina, M., Sullivan, J.L., Luzuriaga, K., and Thorley-Lawson, D.A. (2004). Demonstration of the Burkitt’s lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci USA 101, 239-244.
57. Hudnall, S.D., Ge, Y., Wei, L., Yang, N.P., Wang, H.Q., and Chen, T. (2005). Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18, 519-527.
58. Hughes, R.A. and Rees, J.H. (1997). Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 176(Suppl 2), S92-S98.
59. Imai, S., Usui, N., Sugiura, M. et al. (1993). Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J Med Virol 40, 278-284.
60. Isobe, Y., Sugimoto, K., Yang, L. et al. (2004). Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells. Cancer Res 64, 2167-2174.
61. Joncas, J.H., Chicoine, L., Thivierge, F., and Bertrand, M. (1974). Epstein-Barr virus antibodies in the cerebrospinal fluid. A case of infectious mononucleosis with encephalitis. Am J Dis Child 127, 282-285.
62. Kaji, M. and Shoji, H. (1995). Detection of Epstein-Barr virus genome in peripheral leucocytes and CSF by the polymerase chain reaction in two patients with Epstein-Barr virus related to aseptic meningitis. J Neurol Neurosurg Psychiatry 59, 99.
63. Kasahara, Y., Yachie, A., Takei, K. et al. (2001). Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 98, 1882-1888.
64. Kasamon, Y.L., Nguyen, T.N., Chan, J.A., and Nascimento, A.F. (2002). EBV-associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency. Am J Hematol 69, 289-293.
65. Kis, L.L., Takahara, M., Nagy, N., Klein, G., and Klein, E. (2006). Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Immunol Lett 104, 83-88.
66. Kimura, H., Ito, Y., Suzuki, R., and Nishiyama, Y. (2008). Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol 18, 305-319.
67. Kleines, M., Schiefer, J., Stienen, A., Blaum, M., Ritter, K., and Häusler, M. (2011). Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity. Eur J Clin Microbiol Infect Dis [Epub ahead of print].
68. Klutts, J.S., Ford, B.A., Perez, N.R., and Gronowski, A.M. (2009). Evidence-based approach for interpretation of Epstein-Barr virus serological patterns. J Clin Microbiol 47, 3204-3210.
69. Kogelnik, A.M., Loomis, K., Hoegh-Petersen, M., Rosso, F., Hischier, C., and Montoya, J.G. (2006). Use of valganciclovir in patients with elevated antibody titers against human herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J Clin Virol 37(Suppl 1), S33-38.
70. Kubota, N., Wada, K., Ito, Y. et al. (2008). One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. J Virol Methods 147, 26-36.
71. Kuzushima, K., Hayashi, N., Kudoh, A. et al. (2003). Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8þ T cells. Blood 101, 1460-1468.
72. Landgren, M., Kyllerman, M., Bergstrom, T., Dotevall, L., Ljungstrom, L., and Ricksten, A. (1994). Diagnosis of Epstein-Barr virus-induced central nervous system infections by DNA amplification from cerebrospinal fluid. Ann Neurol 35, 631-635.
73. Leblond, V., Davi, F., Charlotte, F. et al. (1998). Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16, 2052-2059.
74. Lehrnbecher, T., Chittka, B., Nanan, R., Seidenspinner, S., Kreth, H.W., and Schuster, V. (1996). Activated T lymphocytes in the cerebrospinal fluid of a patient with Epstein-Barr virus-associated meningoencephalitis. Pediatr Infect Dis J 15, 631-633.
75. Loureiro, C., Gill, P.S., Meyer, P.R., Rhodes, R., Rarick, M.U., and Levine, A.M. (1988). Autopsy findings in AIDS-related lymphoma. Cancer 62, 735-739.
76. MacMahon, E.M., Glass, J.D., Hayward, S.D. et al. (1991). Epstein-Barr virus in AIDS related primary central nervous system lymphoma. Lancet 338, 969-973.
77. Macsween, K.F. and Crawford, D.H. (2003). Epstein-Barr virus recent advances. Lancet Infect Dis 3, 131-140.
78. Majid, A., Galetta, S.L., Sweeney, C.J. et al. (2002). Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 125, 159-165.
79. Manian, F.A. (1994). Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response? Clin Infect Dis 19, 448-453.
80. Molesworth, S.J., Lake, C.M., Borza, C.M., Turk, S.M., and Hutt-Fletcher, L.M. (2000). Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol 74, 6324-6332.
81. Moore, G.E., Grace, J.T., Citron, P., Gerner, R., and Burns, A. (1966). Leukocyte cultures of patients with leukemia and lymphomas. NY State J Med 66, 2757-2764.
82. Munz, C., Lunemann, J.D., Teague Getts, M., and Miller, S.D. (2009). Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9, 246-258.
83. Niedobitek, G., Hamilton-Dutoit, S., Herbst, H. et al. (1989). Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Hum Pathol 20, 796-799.
84. Obermeier, B., Mentele, R., Malotka, J. et al. (2008). Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 14, 688-693.
85. Otto, C., Oltmann, A., Stein, A., Frenzel, K., Schroeter, J., Habbel, P., Gärtner, B., Hofmann, J., and Ruprecht, K. (2011). Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology 76, 1316-1321.
86. Owens, G., Ritchie, A., Burgoon, M., Williamson, R., Corboy, J., and Gilden, D. (2003). Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 171, 2725-2733.
87. Owens, G., Ritchie, A., Gilden, D., Burgoon, M., Becker, D., and Bennett, J. (2007). Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF. Neurology 68, 1815-1819.
88. Oxman, M.N, Levin M.J., Johnson G.R. et al. (2005). A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352, 2271-2284.
89. Paya, C.V., Fung, J.J., Nalesnik, M.A. et al. (1999). Epstein-Barr virus induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBVPTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 68, 1517-1525.
90. Pedneault, L., Katz, B.Z., and Miller, G. (1992). Detection of Epstein-Barr virus in the brain by the polymerase chain reaction. Ann Neurol 32, 184-192.
91. Peferoen, L.A., Lamers, F., Lodder, L.N. et al. (2010). Epstein-Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 133, e137.
92. Penn, I. (1990). Cancers complicating organ transplantation. N Engl J Med 323, 1767-1769.
93. Penn, I. and Porat, G. (1995). Central nervous system lymphomas in organ allograft recipients. Transplantation 59, 240-244.
94. Pereira, M.S., Blake, J.M., Macrae, A.D. (1969). EB virus antibody at different ages. Br Med J IV, 526-527.
95. Prober, C. (2005). Sixth disease and the ubiquity of human herpesviruses. N Engl J Med 352, 753-755.
96. Qu, L., Green, M., Webber, S., Reyes, J., Ellis, D., and Rowe. D. (2000). Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis 182, 1013-1021.
97. Raez, L., Cabral, L., Cai, J.P. et al. (1999). Treatment of AIDS related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 15, 713-719.
98. Rafailidis, P.I., Mavros, M.N., Kapaskelis, A., and Falagas, M.E. (2010). Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol 49, 151-157. Epub 2010 Aug 24.
99. Reiber, H., Ungefehr, S., and Jacobi, C. (1998). The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4, 111-117.
100. Reiber, H. and Lange, P. (1991). Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37, 1153-1160.
101. Rickinson, A.B. and Kieff, E. (2006). Epstein-Barr virus. In Virology, 5th edition, Vol. 2, Knipe, D.M. and Howly, P.M. (eds), 2655-2700. Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkins.
102. Robinson, T.J., Glenn, M.S., Temple, R.W., Wyatt. D., and Connolly, J.H. (1980). Encephalitis and cerebellar ataxia associated with Epstein-Barr virus infections. Ulster Med J 49, 158-164.
103. Roulet Perez, E., Maeder, P., Cotting, J., Eskenazy-Cottier, A.C., and Deonna, T. (1993). Acute fatal parainfectious cerebellar swelling in two children. A rare or an overlooked situation? Neuropediatrics 24, 346-351.
104. Sairenji, T., Yamanishi, K., Tachibana, Y., Bertoni, G., and Kurata, T. (1995). Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology 38, 269-273.
105. Sanders, V., Felisan. S., Waddell, A., and Tourtellotte, W. (1996). Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 2, 249-258.
106. Sargsyan, S.A., Shearer, A.J., Ritchie, A.M., Burgoon, M.P., Anderson, S., Hemmer, B., Stadelmann, C., Gattenlöhner, S., Owens, G.P., Gilden, D., and Bennett, L.J. (2010). Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 74, 1127-1135.
107. Serafini, B., Rosicarelli, B., Franciotta, D. et al. (2007). Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204, 2899-2912.
108. Shannon-Lowe, C.D., Neuhierl, B., Baldwin, G., Rickinson, A.B., and Delecluse, H.J. (2006). Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 103, 7065-7070.
109. Shian, W.J. and Chi, C.S. (1996). Epstein-Barr virus encephalitis and encephalomyelitis: MR findings. Pediatr Radiol 26, 690-693.
110. Silverstein, A., Steinberg, G., and Nathanson, M. (1972). Nervous system involvement in infectious mononucleosis. The heralding and-or major manifestation. Arch Neurol 26, 353-358.
111. Slobod, K.S., Taylor, G.H., Sandlund, J.T., Furth, P., Helton, K.J., and Sixbey, J.W. (2000). Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system. Lancet 356, 1493-1494.
112. Sparano, J.A., Anand, K., Desai, J., Mitnick, R.J., Kalkut, G.E., and Hanau, L.H. (1999). Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. J Acquir Immune Defic Syndr 21(Suppl 1), S18-S22.
113. Sparano, J.A. (2001). Clinical aspects and management of AIDS related lymphoma. Eur J Cancer 37, 1296-1305.
114. Tabiasco, J., Vercellone, A., Meggetto, F., Hudrisier, D., Brousset, P., and Fournie, J.J. (2003). Acquisition of viral receptor by NK cells through immunological synapse. J Immunol 170, 5993-5998.
115. Tao, Q., Robertson, K.D., Manns, A., Hildesheim, A., and Ambinder, R.F. (1998). Epstein-Barr virus (EBV) in endemic Burkitt’s lymphoma: molecular analysis of primary tumor tissue. Blood 91, 1373-1381.
116. Thorley-Lawson, D.A., and Gross, A. (2004). Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350, 1328-1337.
117. Tierney, R.J., Steven, N., Young, L.S., and Rickinson, A.B. (1994). Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68, 7374-7385.
118. Todman, D.H. (1983). Encephalitis in infectious mononucleosis. Clin Exp Neurol 19, 81-86.
119. Trumper, P.A., Epstein, M.A., Giovanella, B.C., and Finerty, S. (1977). Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma. Int J Cancer 20, 655-662.
120. Tsutsumi, H., Kamazaki, H., Nakata, S. et al. (1994). Sequential development of acute meningoencephalitis and transverse myelitis caused by Epstein-Barr virus during infectious mononucleosis. Pediatr Infect Dis J 13, 665-667.
121. Tugizov, S.M., Berline, J.W., and Palefsky, J.M. (2003). Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9, 307-314.
122. Volpi, A. (2004). EBV and HHV-8 infections of the CNS. HERPES 11(Suppl 2), 120A-127A.
123. Whitley, R.J., Cobbs, C.G., Alford, C.A.J. et al. (1989). Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA 262, 234-239.
124. Willis, S.N., Stadelmann, C., Rodig, S.J. et al. (2009). Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132, 3318-3328.
125. Winer, J.B., Hughes, R.A., Anderson, M.J., Jones, D.M., Kangro, H., and Watkins, R.P. (1988). A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51, 613-618.
126. Xue, S.A., Labrecque, L.G., Lu, Q.L. et al (2002). Promiscuous expression of Epstein-Barr virus genes in Burkitt’s lymphoma from the central African country Malawi. Int J Cancer 99, 635-643.
127. Yoshioka, M., Ishiguro, N., Ishiko, H., Ma, X., Kikuta, H., and Kobayashi, K. (2001). Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection. J Gen Virol 82, 2385-2392.
128. Young, L., Alfieri, C., Hennessy, K. et al. (1989). Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321, 1080-1085.